Scientific article
Review
English

Targeting the epithelial cells in fibrosis: a new concept for an old disease

Published in

Drug discovery today, vol. 18, no. 11-12, p. 582-591

Publication date

2013

Abstract

Fibrosis, which affects millions of individuals worldwide, is a leading cause of organ failure. For 40 years myofibroblasts have been recognized to be the key cellular players in fibrosis. Currently, several pharmaceutical targets are under investigation that may contribute to the activation of myofibroblasts. Recent preclinical and clinical evidence suggests that other components in the fibrotic microenvironment can trigger myofibroblast activation, providing new targets for pharmaceutical intervention. Epithelial cells may represent the most promising cellular phenotype that could be exploited in the design of new anti-fibrotic medicines through their paracrine action on myofibroblasts. The present review briefly highlights this hypothesis and discusses some interesting related pharmacological targets.

Keywords

  • Animals
  • Epithelial Cells/metabolism
  • Fibrosis/drug therapy/metabolism/pathology
  • Humans
  • Myofibroblasts/pathology

Citation (ISO format)

MOLL, Solange et al. Targeting the epithelial cells in fibrosis: a new concept for an old disease. In: Drug discovery today, 2013, vol. 18, n° 11-12, p. 582–591. doi: 10.1016/j.drudis.2013.01.006

Main files (1)

Article (Accepted version)

Identifiers

Journal ISSN

1359-6446
647views
0downloads

Technical informations

Creation

18/12/2014 17:58:00

First validation

18/12/2014 17:58:00

Update

14/03/2023 22:31:00

Status update

14/03/2023 22:31:00

Last indexation

30/10/2024 21:40:34
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated